BIOMICA
Biomica is a biopharmaceutical company that develops microbiome-based therapeutics to treat immune-mediated and infectious diseases, with specific focus on Immuno-Oncology and GI-related disorders.
BIOMICA
Social Links:
Industry:
Big Data Biopharma Biotechnology Health Care Therapeutics
Founded:
2016-02-01
Address:
Rehovot, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.biomicamed.com
Total Employee:
11+
Status:
Active
Contact:
972-8-9311900
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Nginx SingleHop
Similar Organizations
Apogenix
Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.
Epygen Biotech
Epygen Biotech is a biopharmaceutical firm that research and manufacturers therapeutic proteins oncology, cardiovascular, and vaccines.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.biomicamed.com Semrush global rank: 3.96 M Semrush visits lastest month: 3.13 K
- Host name: 62.219.30.253
- IP address: 62.219.30.253
- Location: Hadera Israel
- Latitude: 32.4364
- Longitude: 34.9196
- Timezone: Asia/Jerusalem
More informations about "Biomica"
About Us - Biomica
Faster, highly targeted function-based drug discovery approach. Biomica’s unique function-based drug discovery approach, powered by our proven computational predictive biology platform, …See details»
Biomica
Proven Technology. Unmatched Computational Power. Our drug candidates have been identified and designed using PRISM, a proprietary cutting-edge computational platform that integrates advanced AI capabilities, ‘Big Data’, …See details»
Biomica - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 972-8-9311900 Biomica is a biopharmaceutical company that develops microbiome-based therapeutics to treat immune …See details»
Our Team - Biomica
Dr. Haber serves as Biomica’s Chief Executive Officer. He is a seasoned life-science and biotechnology executive with over 15 years of experience in a range of strategic and …See details»
Biomica Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Biomica. Use the PitchBook Platform to explore the full profile.See details»
Biomica Company Profile - Office Locations, Competitors ... - Craft
See insights on Biomica including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Biomica - Overview, News & Similar companies | ZoomInfo.com
Apr 11, 2024 Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting Preliminary data from Biomica's Phase 1 study of BMC128 will be showcased …See details»
Biomica Successfully Completes Phase I Trial …
Jan 17, 2024 Biomica . Initiated on July 11, 2022, the Phase I trial was specifically designed to evaluate the safety and tolerability of Biomica's microbiome-based immuno-oncology drug candidate, BMC128, in ...See details»
Biomica Raises $20 Million in a Financing Round to …
Dec 21, 2022 Shanghai Healthcare Capital is a leading Chinese private equity fund, based in Shanghai and focused on biotech and healthcare investments globally. The fund's goal is investment in early stage and ...See details»
Biomica Announces First Patient Dosed in its Phase I Study of its ...
REHOVOT, Israel, July 26, 2022 – Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. …See details»
Technology - Biomica - biomicamed.com
Using metagenomics analysis to reveal intricate host microbiome interactions. Using our unique methodology combined with PRISM’s powerful metagenomics analysis tools for high …See details»
Biomica Opens Second Site to Advance Its Immuno-Oncology
REHOVOT, Israel, Aug. 15, 2023 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a …See details»
Biomica to Present at the ASCO 2022 Annual Meeting
May 23, 2022 GRASP, which stands for Guiding Researchers and Advocates to Scientific Partnerships, and is a patient-led organization that brings together patients, clinicians, and …See details»
Biomica & Rambam Health Care Campus Sign Agreement for …
Oct 27, 2021 For more information, please visit www.biomicamed.com. About Rambam Health Care Campus Rambam Health Care Campus is a 1,000-bed academic government hospital …See details»
Biomica Announces Successful Enrollment of First Patient in
Proof of Concept (POC) in-human trial to take place at Rambam Health Care Campus in Israel throughout 2022 REHOVOT, Israel, July 11, 2022. Biomica Ltd., an emerging …See details»
Biomica Raises $20 Million in a Financing Round to Advance its …
Dec 21, 2022 For more information, please visit www.biomicamed.com. About Evogene Ltd. Evogene (Nasdaq: EVGN, TASE: EVGN) is a computational biology company aiming to …See details»
Biomica Announces First Patient Dosed in its Phase I Study of its ...
Jul 26, 2022 Biomica is a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics utilizing a dedicated Computational Predictive Biology …See details»
Biomica Announces Clearance for First-in-Human Phase I Study of …
Jan 11, 2022 Biomica has entered into a supply agreement for the utilization of Bristol Myers Squibb's (BMS) Opdivo® to evaluate the safety and tolerability of BMC-128 therapy in …See details»
Pipeline - Biomica
Harnessing our computational analysis and predictive capabilities, we have identified BMC128, a rationally designed microbial consortium. Developed as a Live Bacterial Product (LBP), …See details»
Biomica Announces Successful Enrollment of First Patient in its …
Jul 11, 2022 The trial is designed primarily to evaluate the safety and tolerability of Biomica's microbiome-based immuno-oncology drug candidate, BMC128, in combination with immune …See details»